iBio Provides Update on IBIO-201 COVID-19 Vaccine Program – GlobeNewswire

NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) — iBio, Inc.
(NYSE AMERICAN:IBIO) (iBio or the Company), a biotechnology corporation and biologics contract manufacturing organization, today provided an u…
Read More